Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.22 SEK | -3.59% | +9.34% | -57.96% |
Apr. 15 | Oncopeptides AB Secures National Reimbursement for Pepaxti in Spain | CI |
Apr. 04 | Oncopeptides AB Provides Sales Guidance for the First Quarter of 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-57.96% | 67.6M | |
+4.84% | 109B | |
+10.81% | 105B | |
-0.38% | 22.25B | |
-12.14% | 22.09B | |
-7.66% | 18.68B | |
-36.52% | 17.58B | |
-9.11% | 16.85B | |
+4.60% | 13.76B | |
+34.85% | 12.46B |
- Stock Market
- Equities
- ONCO Stock
- News Oncopeptides AB
- Swedish Biotech Oncopeptides Appoints New CFO